Weight Loss Pill from Structure Therapeutics Trimmed the Most Pounds Yet. Is the Biotech a Takeover Candidate?
Structure Therapeutics(US:GPCR) Barrons·2026-03-16 22:46公司核心进展 - Structure Therapeutics公司研发的口服GLP-1药片在中期试验中帮助患者减重超过16% [1] - 该试验结果优于已报告的竞争性肥胖症药物 [1]